Standardization Research Center of Traditional Chinese Medicine Dispensing, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Department of Cardiovascular Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Front Public Health. 2022 Dec 8;10:1022810. doi: 10.3389/fpubh.2022.1022810. eCollection 2022.
BACKGROUND: The global community has been affected by the coronavirus disease 2019 (COVID-19), which emerged in December 2019. Since then, many studies have been conducted on cardiovascular diseases (CVDs) and COVID-19. The aim of this study was to perform a bibliometric and visual analysis of the published relationship between CVDs and COVID-19. METHODS: 1,890 publications were retrieved from the Web of Science Core Collection database on January 5, 2022. Microsoft Office Excel and CiteSpace were then used to carry out scientometric analysis on the relevant literature according to seven aspects: document type, countries/regions, institutions, authors, journals, references, and keywords. RESULTS: The research on CVDs and COVID-19 is currently in a period of rapid development, with China, USA, England, and Italy leading the field. There is active cooperation between most countries and institutions. Harvard Medical School stands out among the many institutions not only for the largest number of publications, but also for their high quality. Banerjee A, Solomon SD and Narula J are three representative authors in this field. was the journal with the highest number of published studies, and was the most cited journal. Two documents with a high degree of significance in this field were identified. Popular research topics in this field are specific diseases, such as acute coronary syndrome and heart failure; pathogenesis related to ACE2, insulin resistance and pericyte; the specific therapeutic drug chloroquine; and clinical characteristics, physical activity, and mental health. ACE2 and NF-κB will be the focus of future research. CONCLUSIONS: This study provides useful information for the research of CVDs and COVID-19, including potential collaborators, popular research topics, and a reference for more extensive and in-depth research in the future.
背景:全球受到了 2019 年 12 月出现的新型冠状病毒病(COVID-19)的影响。自那时以来,已经进行了许多关于心血管疾病(CVDs)和 COVID-19 的研究。本研究的目的是对已发表的 CVDs 和 COVID-19 之间关系的文献进行计量学和可视化分析。
方法:2022 年 1 月 5 日,从 Web of Science 核心合集数据库中检索到 1890 篇文献。然后使用 Microsoft Office Excel 和 CiteSpace 根据七个方面对相关文献进行科学计量分析:文献类型、国家/地区、机构、作者、期刊、参考文献和关键词。
结果:目前,CVDs 和 COVID-19 的研究正处于快速发展阶段,中国、美国、英国和意大利处于领先地位。大多数国家和机构之间存在积极的合作。哈佛医学院不仅在发表文献数量最多,而且在质量方面也脱颖而出。Banerjee A、Solomon SD 和 Narula J 是该领域的三位代表性作者。《柳叶刀-呼吸医学》是发表研究最多的期刊,《柳叶刀》是被引频次最高的期刊。该领域有两篇具有高度重要性的文献。该领域的热门研究主题是特定疾病,如急性冠状动脉综合征和心力衰竭;与 ACE2、胰岛素抵抗和周细胞相关的发病机制;特定治疗药物氯喹;以及临床特征、身体活动和心理健康。ACE2 和 NF-κB 将成为未来研究的重点。
结论:本研究为 CVDs 和 COVID-19 的研究提供了有用的信息,包括潜在的合作者、热门研究主题,以及未来更广泛和深入研究的参考。
Front Public Health. 2022
Medicine (Baltimore). 2022-9-30
Ann Med Surg (Lond). 2023-12-19
Front Public Health. 2022
Transplant Proc. 2023-10
Front Public Health. 2022
Clin Exp Med. 2023-10
Medicine (Baltimore). 2025-8-8
J Gastrointest Cancer. 2025-6-19
Medicine (Baltimore). 2024-6-7
Med Hypothesis Discov Innov Ophthalmol. 2023-12-31
Ann Med Surg (Lond). 2023-12-19
Front Cardiovasc Med. 2022-7-27
Front Immunol. 2021
Front Pharmacol. 2021-7-15
Front Psychol. 2021-6-3
JACC Cardiovasc Imaging. 2021-9
Glob Heart. 2021-4-19